MedTrace Logo

Xenogenic Collagen Matrix and Subepithelial Connective Tissue Graft in the Treatment of Gingival Recession

NCT04082130 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2021-01-12

No results posted yet for this study

Summary

this study is a Clinical evaluation of using Xenogenic collagen matrix (XCM) plus coronally advanced flap (CAF) compared to subepithelial connective tissue graft (SCTG) plus coronally advanced flap to treat Miller class I gingival recession. A split-full-split thickness flap will be elevated in the (XCM+CAF) group while it will be an only partial thickness flap in the (SCTG+CAF) group. The sample size will be 15 patients. Each patient has bilateral Miller Class I gingival recessions; and as a split-mouth study design one side will be treated with (SCTG+CAF), while the other will be treated with (XCM+CAF).

Conditions

  • Gingival Recession Localized Moderate

Interventions

PROCEDURE

(XCM)+(CAF)

The description of this intervention has been already given before.

PROCEDURE

(SCTG)+(CAF)

The description of this intervention has been already given before.

Sponsors & Collaborators

  • Damascus University

    lead OTHER

Principal Investigators

  • Noor Alhuda Ewaz Ali, DDS · MSc student in Periodontics, University of Damascus Dental School

  • Suleiman Dayoub, DDS MSc PhD · Professor of Periodontics, University of Damascus Dental School

  • Mohammad Alharissy, DDS MSc PhD · Assistant Professor of Periodontics, Academic Staff Member At Wadi International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
47 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-25
Primary Completion
2020-06-30
Completion
2020-08-01

Countries

  • Syria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04082130 on ClinicalTrials.gov